Glass House Brands announced Q1 2026 revenue of $40.5 million, slightly down from $44.8 million a year ago, with a gross margin of 25% and negative adjusted EBITDA of $4.2 million. The company is focusing on expanding production capacity, targeting approximately 1 million pounds of cannabis biomass for 2026 and aiming to reduce production costs to $95 per pound in the second half of the year. Glass House also highlighted progress in medical cannabis rescheduling and DEA registration, which could open new markets and improve profitability. Despite short-term cost pressures, management remains confident in revenue growth and operational improvements throughout 2026.
Willis Towers Watson, a global advisory firm, is poised for growth with a 25.3% potential stock upside, driven by new initiatives like KwantSure, a digital insurance sales channel for subcontractors, and a Geospatial Mortality Model to improve pensio...
AngioDynamics reported an 8% revenue increase to $86.6 million in Q4, driven by a 16.7% sales rise in its Med Tech division, notably from NanoKnife and AlphaVac products. H.C. Wainwright raised the price target from $16 to $19 and maintained a Buy ra...
PNC Financial Services Group reported Q2 2026 adjusted EPS of $4.85 and record revenue of $6.88 billion, surpassing analyst expectations. The growth was driven by a 15.5% rise in net interest income and a 31.4% increase in fee income, reflecting stro...
Greenlight, a leading cannabis operator, expanded its Ohio presence by opening four new dispensaries and adding in-state manufacturing, reaching the state's maximum allowed eight dispensaries. This move strengthens Greenlight's position in Ohio's lim...
Halper Sadeh LLC is investigating whether shareholders of Element Solutions Inc (ESI), Crinetics Pharmaceuticals (CRNX), and Solstice Advanced Materials (SOLS) are receiving fair treatment in their respective sale and merger transactions. The firm hi...
